Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 16Gastrointestinal 8Genitourinary 6Myeloid 4Lymphoid 4CNS 4Gynecologic 3Dermatologic 2Thoracic 1Other solid neoplasm 1Breast 1

Conditions

Breast Neoplasms 56Triple Negative Breast Neoplasms 28Lung Neoplasms 12Prostatic Neoplasms 10Neoplasm Metastasis 10Carcinoma, Intraductal, Noninfiltrating 10Anatomic Stage I Breast Cancer AJCC v8 9Carcinoma, Non-Small-Cell Lung 8Breast Carcinoma In Situ 8Ovarian Neoplasms 6Melanoma 6Stomach Neoplasms 5Pancreatic Neoplasms 5Meningeal Carcinomatosis 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Multiple Myeloma 4Colonic Neoplasms 4Brain Neoplasms 4Anatomic Stage IV Breast Cancer AJCC v8 4Small Cell Lung Carcinoma 3Inflammatory Breast Neoplasms 3Esophageal Neoplasms 3Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2

Interventions

pembrolizumab 10Gemcitabine 8Cyclophosphamide 7Filgrastim 5Docetaxel 5Carboplatin 5Trastuzumab 4Surveys and Questionnaires 4Nivolumab 4Doxorubicin 4Cisplatin 4poly ICLC 3pazopanib 3atezolizumab 3aldesleukin 3Taxes 3Radiotherapy 3Paclitaxel 3Oncolytic Virotherapy 3Irinotecan 3Ipilimumab 3Injections 3Drug Therapy 3Cetuximab 3Capecitabine 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3spartalizumab 2palbociclib 2liposomal doxorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Specimen Handling × Breast × Clear all
NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡